CNSP vs UNP · $6.6M cap vs P/E 21, rev $6.86B
CNS Pharmaceuticals Inc (CNSP) versus Union Pacific Corporation (UNP) — a side-by-side from cached financials, not a winner call.
CNS Pharmaceuticals Inc (CNSP) is a biotechnology company listed on NASDAQ.
Union Pacific Corporation (UNP) is a railroads company listed on NYSE.
CNSP does not have a complete income-statement cache yet.
Latest reported UNP revenue for 2026-06-30 was $6.86B. Net income was $1.99B. Revenue was up 10.4% from 2026-03-31 to 2026-06-30. UNP currently screens at market cap $153.21B and trailing P/E 21.3.
CNSP currently screens at market cap $6.6M. UNP currently screens at market cap $153.21B and trailing P/E 21.3.
Not investment advice. Open the CNSP and UNP stock pages for the full models.
Not investment advice.